Related Herbs
Botanicals connected by the same goals, effects, or research topics.
Herb Profile
Curcuma longa
Turmeric (Curcuma longa) is a culinary rhizome whose curcuminoids, including curcumin and demethoxycurcumin, are studied in concentrated extracts.
Use extra caution — Safety evidence: short term human trials provide limited, preparation specific safety data. Details

Best for
Not ideal for
Safety: Culinary amounts are well tolerated. Concentrated supplements carry the same cautions as curcumin: anticoagulant interaction, gallstones, and rare liver-injury reports.
On the evidence: Nearly all positive human evidence comes from standardized curcuminoid extracts, not whole turmeric at dietary intakes.
Consider instead: Curcumin — this is the form the clinical trials actually tested
Start here
New to this? Begin with Anti-inflammatory supplements.
Compare first
Continue reading
Informational to commercial: understand turmeric versus curcumin, bioavailability forms, joint/inflammation evidence, and safety cautions before buying.
| Use case | Evidence | Best fit | Typical range | Safety context |
|---|---|---|---|---|
| Joint comfort / osteoarthritis | Moderate | Adults comparing non-NSAID joint-support options | Often 500-1,000 mg/day curcuminoids or formulated equivalent | Medication and gallbladder context matter. |
| Inflammatory signaling | Mechanistic to moderate | NF-kB/Nrf2 pathway context | Form-dependent; do not infer from spice dose | Do not treat inflammatory disease without care. |
| Gut and metabolic context | Preliminary | Curcumin-focused experiments | Trial-dependent extracts | Can aggravate reflux or GI upset. |
| Plain turmeric powder | Low for targeted effects | Food use, not high-potency supplementation | Culinary amounts vary | Low dose but lower bioavailability. |
Safety
Safety evidence: short term human trials provide limited, preparation specific safety data. Mild gastrointestinal effects can occur; the existing workbook cautions for bleeding risk therapy, surgery, biliary disease, pregnancy, and breastfeeding remain precautionary and require individualized review.
High caution
Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.
Evidence-based safety
Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.
Bleeding / anticoagulant risk
Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.
Data provenance recorded for 147 of 147 pairings in this mechanism group.
+135 more pairings share this mechanism. Use the Safety Checker to review a specific combination.
Evidence
Useful signal, but study design, dose, and population still matter.
Human clinical evidence: Present in source signals
Mechanistic / preclinical: Mechanism mapped — Inflammatory Signaling Modulation · Oxidative Stress Modulation · Metabolic Regulation
Research maturity: Established research — Long Term Human Evidence May Be Limited.
Safety boundary: Safety note available — Safety evidence: short term human trials provide limited, preparation specific safety data.
This profile cites 4 human studies.
Evaluation of methodological rigor, population reach, and evidence alignment.
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
Filter by study class
Showing 4 of 4 studies.
What the evidence actually shows
This table contains 4 structured sources, including 2 human evidence sources; 1 is a human trial. Across 1 human evidence source with a reported sample size, the approximate participant total is 367; overlapping publications may include some of the same people. Source-to-conclusion relationships are not classified in this structured set, so consistency is not yet classifiable.
Profile-wide evidence grade: see the profile grade above · Confidence: not separately assigned
What would change our conclusion?
Larger, well-controlled human trials using comparable populations, doses, preparations, and clinically meaningful outcomes could materially strengthen or weaken this conclusion. Replication in a different population or a high-quality synthesis resolving current disagreement could also materially change confidence.
| Study | Design | N | Dose | Duration | Population | Outcome | Result & magnitude | Source |
|---|---|---|---|---|---|---|---|---|
Effects of Turmeric (Curcuma longa) on Skin Health: A Systematic Review of the Clinical Evidence Vaughn AR et al. · Phytother Res · 2016 Background | Systematic review Uses a predefined method to find and evaluate relevant studies, but may or may not pool their results statistically. | — | — | — | — | — | — | PubMed → |
PubMed · Clin Interv Aging · 2014 Background | Randomized controlled trial Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well. | n=367 | — | — | — | — | — | PubMed → |
Curcumin, an active component of turmeric (Curcuma longa), and its effects on health Kocaadam B et al. · Crit Rev Food Sci Nutr · 2017 Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | — | PubMed → |
Ayurvedic Herbal Medicines: A Literature Review of Their Applications in Female Reproductive Health Patibandla S et al. · Cureus · 2024 Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | — | PubMed → |
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Turmeric Curcuma Longa Works
Preclinical pathways. Proposed mechanisms from in vitro and animal research; these do not confirm clinical outcomes in humans.
Key constituents studied in Turmeric Curcuma Longa, with full pharmacology and safety profiles.
Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.
Condition guides
Compare side-by-side tradeoffs or verify active marker guidelines.
Sourcing options
Product recommendations are not shown for this profile because the current site safety and monetization policy does not permit them.
When sourcing Turmeric Curcuma Longa, verify the label for:
Continue comparing
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Help improve this profile
These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.
Was this evidence summary clear?
Did you find what you were researching?
Free safety checklist
Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.